Trial Search Results

Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting

This randomized pilot clinical trial studies giving acupuncture in reducing nausea and vomiting in patients undergoing chemotherapy. Pressing and stimulating nerves at an acupuncture point on the inside of the wrist may help control nausea and vomiting during chemotherapy.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Cancer Institute (NCI)

Stanford Investigator(s):


  • Procedure: electroacupuncture therapy
  • Other: questionnaire administration
  • Procedure: electroacupuncture therapy




Inclusion Criteria:

   - Patient with a planned admission for at least 24 hours for highly emetogenic or
   moderately emetogenic chemotherapy at Lucile Packard Children's Hospital or Packard El

   - Planned to undergo at least 2 more cycles of chemotherapy.

   - Can include but not limited to: children with high risk ALL, AML, Ewing's Sarcoma,

   - History of vomiting with prior cycles of chemotherapy (2 episodes of emesis at
   minimum) despite use of conventional antiemetic medications.

   - Age 8-21.

   - Parent must be able to understand and willing to sign written informed consent

Exclusion Criteria:

   - Prior knowledge of acupuncture or experience with acupuncture or acupressure.

   - There will be no restrictions regarding use of other Investigational Agents.

   - Comorbid Diseases:

      - Diagnosis of any cardiac condition (cardiomyopathy, arrhythmia, pacemaker

      - Any diagnosis requiring pediatric intensive care unit admission.

      - Patients with brain tumor, brain metastasis (these patients often require
      radiation and surgery in addition to chemotherapy which may confound the results)

      - Concomitant radiation therapy during current chemotherapy cycle.

      - Developmental delay patients with allergy to tape or leads will be excluded from
      the study.

   - Pregnant patients will be excluded from the study.

   - Cancer survivors will not be excluded from the study as long as they are undergoing
   chemotherapy treatment for their current cancer therapy.

   - HIV-positive patients will not be excluded.

Ages Eligible for Study

8 Years - 21 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Brenda Golianu
Not Recruiting